Cite
HARVARD Citation
Katoh, T. et al. (2021). Cardiovascular safety of mirabegron add‐on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study. LUTS. 13 (1), pp. 98-107. [Online].